Status:

ACTIVE_NOT_RECRUITING

IGNITE Firefighters' Health

Lead Sponsor:

Stanford University

Conditions:

Cancer

Inflammation

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Investigators hope to learn about potential dietary intervention strategies (specifically a whole-food, plant-based diet) that may help lower cancer markers in firefighters.

Detailed Description

The purpose of the San Francisco (SF) Firefighter's Diet Study is to determine if a diet low in processed foods, mostly plant-based, with added fermented foods, can lower the risk of cancer in firefig...

Eligibility Criteria

Inclusion

  • Age 18+
  • Active SF firefighter
  • Willing to consume a plant-based diet (vegetables, fruit, whole grains, legumes, etc.)
  • Willing to complete 4 clinic visits

Exclusion

  • Weight \< 110 lb
  • BMI \>= 40
  • Self-reported uncontrolled hypercholesterolemia, hypertension or diabetes
  • Pregnant, lactating, or planning to become pregnant during the course of the study.
  • Use of any of the following drugs/supplements within the last 2 months:
  • systemic antibiotics, antifungals, antivirals, or antiparasitics (intravenous, intramuscular, or oral);
  • corticosteroids (intravenous, intramuscular, oral, nasal or inhaled);
  • cytokines;
  • methotrexate or immunosuppressive cytotoxic agents.
  • Chronic, clinically significant, or unstable (unresolved, requiring ongoing changes to medical management or medication) pulmonary, cardiovascular, gastrointestinal, hepatic or renal functional abnormality, as determined by medical history, Type 1 diabetes, dialysis
  • History of active cancer in the past 3 years except for squamous or basal cell carcinomas of the skin that have been medically managed by local excision
  • Unstable dietary history as defined by major changes in diet during the previous month, where the subject has eliminated or significantly increased a major food group in the diet.
  • Recent history of chronic excessive alcohol consumption defined as more than five 1.5-ounce servings of 80 proof distilled spirits, five 12-ounce servings of beer or five 5-ounce servings of wine per day; or \> 14 drinks/week.
  • Any confirmed or suspected condition/state of immunosuppression or immunodeficiency (primary or acquired) including HIV infection, multiple sclerosis, and Graves' disease.
  • Surgery of the GI tract, with the exception of cholecystectomy and appendectomy, in the past five years. Any major bowel resection at any time.
  • Regular/frequent use of smoking or chewing tobacco, e-cigarettes, cigars or other nicotine-containing products
  • Regular use of prescription opiate pain medication

Key Trial Info

Start Date :

January 9 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 30 2026

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT06567561

Start Date

January 9 2025

End Date

March 30 2026

Last Update

January 9 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Stanford University

Palo Alto, California, United States, 94305